STABILIZED PHARMACEUTICAL SYRUP COMPOSITION COMPRISING TERBUTALINE SULPHATE AND AMBROXOL HYDROCHLORIDE

The invention relates to develop a stable, combination of terbutaline sulphate and ambroxol hydrochloride pharmaceutical compositions of syrup for treatment of bronchial asthma. This syrup is stabilized against degradation of the active ingredients by formulating with specific amount of thickening a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PINARBASLI, Onur, ÖNCEL, Hatice, ÇAPAN, Yilmaz, BILGIN, Feristah, SARRAÇOGLU, Nagehan
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to develop a stable, combination of terbutaline sulphate and ambroxol hydrochloride pharmaceutical compositions of syrup for treatment of bronchial asthma. This syrup is stabilized against degradation of the active ingredients by formulating with specific amount of thickening agent in unit dose (w/v %) and adjusting the final pH value of the product into a specific range. Also, this product is used for the treatment of bronchial asthma with maintenance treatment of lung diseases that have emerged as a secretion complication of asthma and bronchospasm.